LRRK2 Kinase Inhibition Attenuates Astrocytic Activation in Response to Amyloid β1-42 Fibrils
Authors:
Open Access
- 6 February 2023
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 13 (2) , 307
Abstract
Intracerebral accumulation of amyloid-β in the extracellular plaques of Alzheimer’s disease (AD) brains represents the main cause of reactive astrogliosis and neuroinflammatory response. Of relevance, leucine-rich repeat kinase 2 (LRRK2), a kinase linked to genetic and sporadic Parkinson’s disease (PD), has been identified as a positive mediator of neuroinflammation upon different inflammatory stimuli, however its pathogenicity in AD remains mainly unexplored. In this study, by using pharmacological inhibition of LRRK2 and murine primary astrocytes, we explored whether LRRK2 regulates astrocytic activation in response to amyloid-β1-42 (Aβ1-42). Our results showed that murine primary astrocytes become reactive and recruit serine 935 phosphorylated LRRK2 upon Aβ1-42 fibril exposure. Moreover, we found that pharmacological inhibition of LRRK2, with two different kinase inhibitors, can attenuate Aβ1-42-mediated inflammation and favor the clearance of Aβ1-42 fibrils in astrocytes. Overall, our findings report that LRRK2 kinase activity modulates astrocytic reactivity and functions in the presence of Aβ1-42 deposits and indicate that PD-linked LRRK2 might contribute to AD-related neuroinflammation and pathogenesis.Keywords
Funding Information
- Ministero della Salute (GR-2016-02362548, Ricerca Corrente 2021)
This publication has 77 references indexed in Scilit:
- LRRK2 kinase inhibition prevents pathological microglial phagocytosis in response to HIV-1 Tat proteinJournal of Neuroinflammation, 2012
- Impaired Inflammatory Responses in Murine Lrrk2-Knockdown Brain MicrogliaPLOS ONE, 2012
- Astrocytes are important mediators of Aβ-induced neurotoxicity and tau phosphorylation in primary cultureCell Death & Disease, 2011
- Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2Nature Chemical Biology, 2011
- Epidemiology of Alzheimer diseaseNature Reviews Neurology, 2011
- Decreased Clearance of CNS β-Amyloid in Alzheimer’s DiseaseScience, 2010
- Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser910/Ser935, disruption of 14-3-3 binding and altered cytoplasmic localizationBiochemical Journal, 2010
- Mechanisms Underlying Inflammation in NeurodegenerationCell, 2010
- The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspectiveJournal of Neuroinflammation, 2008
- A Century of Alzheimer's DiseaseScience, 2006